Elanco Animal Health (ELAN) Stock Forecast & Price Target
ELAN Analyst Ratings
Strong Buy
12Buy2Hold0Sell
Based on 14 analysts giving stock ratings to Elanco Animal Health in the past 3 months
ELAN Stock 12 Month Forecast
Average Price Target
MXN 580.82▲(52.85% Upside)Based on 14 Wall Street analysts offering 12 month price targets for Elanco Animal Health in the last 3 months. The average price target is MXN 580.82 with a high forecast of MXN 638.75 and a low forecast of MXN 450.88. The average price target represents a 52.85% change from the last price of MXN 380.00.
Past 12 Months12 Month ForecastJan2026Oct2026
HighMXN 638.75
AverageMXN 580.82
LowMXN 450.88
Highest Price TargetHighestMXN 638.75Average Price TargetMXN 580.82Lowest Price TargetLowestMXN 450.88
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Erin Wright | Morgan Stanley | MXN 488.46→MXN 469.67 | hold | 23.60%Upside | Assigned | 10/30/26 | ||
| Andrea Alfonso | UBS | MXN 619.96 | buy | 63.15%Upside | Reiterated | 10/26/26 | ||
| Keith Devas | Jefferies | MXN 582.39→MXN 450.88 | hold | 18.65%Upside | Downgraded | 10/20/26 | ||
| Chris Schott | J.P. Morgan | MXN 619.96 | buy | 63.15%Upside | Reiterated | 10/16/26 | ||
| Matthew Dellatorre | Goldman Sachs | MXN 601.18 | buy | 58.20%Upside | Initiated | 10/15/26 | ||
| Daniel Clark | Leerink Partners | MXN 638.75 | buy | 68.09%Upside | Reiterated | 10/01/26 | ||
| Jonathan Block | Stifel Nicolaus | ― | buy | ― | Reiterated | 09/18/26 | ||
| Steve Scala | TD Cowen | MXN 601.18 | buy | 58.20%Upside | Assigned | 08/25/26 | ||
| Glen Santangelo | Barclays | MXN 563.60 | buy | 48.32%Upside | Reiterated | 08/21/26 | ||
| Brandon Vazquez | William Blair | ― | buy | ― | Reiterated | 08/12/26 | ||
| Michael Ryskin | Bank of America Securities | MXN 601.18→MXN 638.75 | buy | 68.09%Upside | Reiterated | 08/12/26 | ||
| David Westenberg | Piper Sandler | MXN 563.60 | buy | 48.32%Upside | Reiterated | 08/10/26 | ||
| Scott Schoenhaus | KeyBanc | MXN 563.60 | buy | 48.32%Upside | Reiterated | 08/06/26 | ||
| Daniel Grosslight | Citi | MXN 582.39→MXN 638.75 | buy | 68.09%Upside | Reiterated | 08/06/26 | ||
| Jasper Hellweg | Argus Research | ― | buy | ― | Reiterated | 06/23/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Erin Wright | 10/30/26 | MXN 488.46→MXN 469.67 | hold | 23.60%Upside | Assigned | Morgan Stanley | ||
| Andrea Alfonso | 10/26/26 | MXN 619.96 | buy | 63.15%Upside | Reiterated | UBS | ||
| Keith Devas | 10/20/26 | MXN 582.39→MXN 450.88 | hold | 18.65%Upside | Downgraded | Jefferies | ||
| Chris Schott | 10/16/26 | MXN 619.96 | buy | 63.15%Upside | Reiterated | J.P. Morgan | ||
| Matthew Dellatorre | 10/15/26 | MXN 601.18 | buy | 58.20%Upside | Initiated | Goldman Sachs | ||
| Daniel Clark | 10/01/26 | MXN 638.75 | buy | 68.09%Upside | Reiterated | Leerink Partners | ||
| Jonathan Block | 09/18/26 | ― | buy | ― | Reiterated | Stifel Nicolaus | ||
| Steve Scala | 08/25/26 | MXN 601.18 | buy | 58.20%Upside | Assigned | TD Cowen | ||
| Glen Santangelo | 08/21/26 | MXN 563.60 | buy | 48.32%Upside | Reiterated | Barclays | ||
| Brandon Vazquez | 08/12/26 | ― | buy | ― | Reiterated | William Blair | ||
| Michael Ryskin | 08/12/26 | MXN 601.18→MXN 638.75 | buy | 68.09%Upside | Reiterated | Bank of America Securities | ||
| David Westenberg | 08/10/26 | MXN 563.60 | buy | 48.32%Upside | Reiterated | Piper Sandler | ||
| Scott Schoenhaus | 08/06/26 | MXN 563.60 | buy | 48.32%Upside | Reiterated | KeyBanc | ||
| Daniel Grosslight | 08/06/26 | MXN 582.39→MXN 638.75 | buy | 68.09%Upside | Reiterated | Citi | ||
| Jasper Hellweg | 06/23/26 | ― | buy | ― | Reiterated | Argus Research |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Elanco Animal Health
3 Months
Success Rate10/16 ratings generated profit
63%
Average Return
+11.38%
Copying Steve Scala's trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +11.38% per trade.
1 Year
Success Rate20/26 ratings generated profit
77%
Average Return
+30.46%
Copying Jonathan Block's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +30.46% per trade.
2 Years
Success Rate23/26 ratings generated profit
88%
Average Return
+45.10%
Copying Jonathan Block's trades and holding each position for 2 Years would result in 88.46% of your transactions generating a profit, with an average return of +45.10% per trade.
ELAN Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 2 | 1 |
| Buy | 12 | 17 | 12 | 15 | 4 |
| Hold | 4 | 4 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 16 | 22 | 16 | 20 | 7 |
In the current month, ELAN has received 5 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ELAN average Analyst price target in the past 3 months is 580.82.
ELAN Financial Forecast
HighMXN 3.95
ConsensusMXN 3.81
LowMXN 3.57
ELAN Earnings Forecast
Next quarter’s earnings estimate for ELAN is MXN 3.81 with a range of MXN 3.57 to MXN 3.95. The previous quarter’s EPS was MXN 6.39. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 23.1B
ConsensusMXN 22.7B
LowMXN 22.5B
ELAN Sales Forecast
Next quarter’s sales forecast for ELAN is MXN 22.70B with a range of MXN 22.50B to MXN 23.13B. The previous quarter’s sales results were MXN 25.70B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
ELAN Stock Forecast FAQ
What is MX:ELAN’s average 12-month price target, according to analysts?
Based on analyst ratings, Elanco Animal Health’s 12-month average price target is Mex$580.82.
What is MX:ELAN’s upside potential, based on the analysts’ average price target?
Elanco Animal Health has 52.85% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Elanco Animal Health a Buy, Sell or Hold?
Elanco Animal Health has a consensus rating of Strong Buy, which is based on 12 buy ratings, 2 hold ratings and 0 sell ratings.
What is Elanco Animal Health’s share price target?
The average share price target for Elanco Animal Health is Mex$580.82. This is based on 14 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$638.75, and the lowest forecast is Mex$450.88. The average share price target represents a 52.85% increase from the current price of Mex$380.
What do analysts say about Elanco Animal Health?
Elanco Animal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Street analysts.
How can I buy shares of Elanco Animal Health?
To buy shares of MX:ELAN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.